Table of contents
March 2022 - Volume 60 - 3
Editorial
- Is the path to greener inhalers paved with good intentions? (1 February, 2022)
DTB Select
- Molnupiravir in unvaccinated patients with COVID-19 (31 January, 2022)
- Dapagliflozin no longer licensed for type 1 diabetes (11 January, 2022)
- Risk of medicine-related harms in primary care (27 January, 2022)
- Extended versus immediate-release metformin (4 February, 2022)
DTB Drug review
- Naldemedine for opioid-induced constipation (23 February, 2022)